These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12107853)

  • 21. A model of anticholinergic activity of atypical antipsychotic medications.
    Chew ML; Mulsant BH; Pollock BG; Lehman ME; Greenspan A; Kirshner MA; Bies RR; Kapur S; Gharabawi G
    Schizophr Res; 2006 Dec; 88(1-3):63-72. PubMed ID: 16928430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel antipsychotics: comparison of weight gain liabilities.
    Wirshing DA; Wirshing WC; Kysar L; Berisford MA; Goldstein D; Pashdag J; Mintz J; Marder SR
    J Clin Psychiatry; 1999 Jun; 60(6):358-63. PubMed ID: 10401912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The potential cardiotoxicity of antipsychotic drugs as assessed by heart rate variability.
    Silke B; Campbell C; King DJ
    J Psychopharmacol; 2002 Dec; 16(4):355-60. PubMed ID: 12503835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Olanzapine plasma concentration, average daily dose, and interaction with co-medication in schizophrenic patients.
    Bergemann N; Frick A; Parzer P; Kopitz J
    Pharmacopsychiatry; 2004 Mar; 37(2):63-8. PubMed ID: 15048613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia.
    Citrome L; Volavka J; Czobor P; Sheitman B; Lindenmayer JP; McEvoy J; Cooper TB; Chakos M; Lieberman JA
    Psychiatr Serv; 2001 Nov; 52(11):1510-4. PubMed ID: 11684748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clozapine, quetiapine and olanzapine among addicted schizophrenic patients: towards testable hypotheses.
    Potvin S; Stip E; Roy JY
    Int Clin Psychopharmacol; 2003 May; 18(3):121-32. PubMed ID: 12702890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unanticipated plasma concentrations in two clozapine-treated patients.
    Alfaro CL; McClure RK; Vertrees JE; Benavides R
    Ann Pharmacother; 2001 Sep; 35(9):1028-31. PubMed ID: 11573850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Olanzapine: preclinical pharmacology and recent findings.
    Moore NA
    Br J Psychiatry Suppl; 1999; (37):41-4. PubMed ID: 10211141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Childhood-onset schizophrenia: an open-label study of olanzapine in adolescents.
    Kumra S; Jacobsen LK; Lenane M; Karp BI; Frazier JA; Smith AK; Bedwell J; Lee P; Malanga CJ; Hamburger S; Rapoport JL
    J Am Acad Child Adolesc Psychiatry; 1998 Apr; 37(4):377-85. PubMed ID: 9549958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism.
    Duncan GE; Miyamoto S; Leipzig JN; Lieberman JA
    J Pharmacol Exp Ther; 2000 Apr; 293(1):8-14. PubMed ID: 10734147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma levels of clozapine and norclozapine in Mexican schizophrenia patients.
    González-Esquivel DF; Castro N; Ramírez-Bermúdez J; Custodio V; Rojas-Tomé S; Castro-Román R; Jung-Cook H
    Arzneimittelforschung; 2011; 61(6):335-9. PubMed ID: 21827043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioral pharmacology of olanzapine: a novel antipsychotic drug.
    Moore NA; Leander JD; Benvenga MJ; Gleason SD; Shannon H
    J Clin Psychiatry; 1997; 58 Suppl 10():37-44. PubMed ID: 9265915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Olanzapine concentrations in clinical serum and postmortem blood specimens--when does therapeutic become toxic?
    Robertson MD; McMullin MM
    J Forensic Sci; 2000 Mar; 45(2):418-21. PubMed ID: 10782964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting Plasma Olanzapine Concentration Following a Change in Dosage: A Population Pharmacokinetic Study.
    Tsuboi T; Bies RR; Suzuki T; Takeuchi H; Nakajima S; Graff-Guerrero A; Mamo DC; Caravaggio F; Plitman E; Mimura M; Pollock BG; Uchida H
    Pharmacopsychiatry; 2015 Nov; 48(7):286-91. PubMed ID: 26506574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of plasma levels of olanzapine and N-desmethyl-olanzapine to monitor metabolic parameters in patients with schizophrenia.
    Lu ML; Chen CH; Kuo PT; Lin CH; Wu TH
    Schizophr Res; 2018 Mar; 193():139-145. PubMed ID: 28720417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder.
    Bilder RM; Goldman RS; Volavka J; Czobor P; Hoptman M; Sheitman B; Lindenmayer JP; Citrome L; McEvoy J; Kunz M; Chakos M; Cooper TB; Horowitz TL; Lieberman JA
    Am J Psychiatry; 2002 Jun; 159(6):1018-28. PubMed ID: 12042192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone].
    Bret P; Bonnet F; Bret MC; Jaffré A
    Encephale; 2002; 28(4):329-42. PubMed ID: 12232542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevation of prolactin levels by atypical antipsychotics.
    Turrone P; Kapur S; Seeman MV; Flint AJ
    Am J Psychiatry; 2002 Jan; 159(1):133-5. PubMed ID: 11772702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo biochemistry of olanzapine: a novel, atypical antipsychotic drug.
    Bymaster FP; Rasmussen K; Calligaro DO; Nelson DL; DeLapp NW; Wong DT; Moore NA
    J Clin Psychiatry; 1997; 58 Suppl 10():28-36. PubMed ID: 9265914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex.
    Gessa GL; Devoto P; Diana M; Flore G; Melis M; Pistis M
    Neuropsychopharmacology; 2000 Jun; 22(6):642-9. PubMed ID: 10788763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.